rs6993502

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBS1BS2

The NM_020361.5(CPA6):​c.117-41480T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0299 in 152,272 control chromosomes in the GnomAD database, including 87 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.030 ( 87 hom., cov: 32)

Consequence

CPA6
NM_020361.5 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.711

Publications

3 publications found
Variant links:
Genes affected
CPA6 (HGNC:17245): (carboxypeptidase A6) The gene encodes a member of the peptidase M14 family of metallocarboxypeptidases. The encoded preproprotein is proteolytically processed to generate the mature enzyme, which catalyzes the release of large hydrophobic C-terminal amino acids. This enzyme has functions ranging from digestion of food to selective biosynthesis of neuroendocrine peptides. Mutations in this gene may be linked to epilepsy and febrile seizures, and a translocation t(6;8)(q26;q13) involving this gene has been associated with Duane retraction syndrome. [provided by RefSeq, May 2016]
CPA6 Gene-Disease associations (from GenCC):
  • benign familial mesial temporal lobe epilepsy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • familial mesial temporal lobe epilepsy with febrile seizures
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • familial temporal lobe epilepsy 5
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • febrile seizures, familial, 11
    Inheritance: AR Classification: LIMITED Submitted by: Ambry Genetics
  • epilepsy
    Inheritance: AD, AR Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.97).
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.0299 (4560/152272) while in subpopulation AFR AF = 0.0461 (1914/41546). AF 95% confidence interval is 0.0444. There are 87 homozygotes in GnomAd4. There are 2130 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 87 AR,AD gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_020361.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CPA6
NM_020361.5
MANE Select
c.117-41480T>C
intron
N/ANP_065094.3
CPA6
NM_001440615.1
c.117-41480T>C
intron
N/ANP_001427544.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CPA6
ENST00000297770.10
TSL:1 MANE Select
c.117-41480T>C
intron
N/AENSP00000297770.4Q8N4T0-1
CPA6
ENST00000479862.6
TSL:1
n.117-41480T>C
intron
N/AENSP00000419016.2Q8N4T0-3
CPA6
ENST00000518549.1
TSL:1
n.331-41480T>C
intron
N/A

Frequencies

GnomAD3 genomes
AF:
0.0298
AC:
4538
AN:
152154
Hom.:
83
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0457
Gnomad AMI
AF:
0.0373
Gnomad AMR
AF:
0.0350
Gnomad ASJ
AF:
0.00749
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.00248
Gnomad FIN
AF:
0.00556
Gnomad MID
AF:
0.0316
Gnomad NFE
AF:
0.0279
Gnomad OTH
AF:
0.0344
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.0299
AC:
4560
AN:
152272
Hom.:
87
Cov.:
32
AF XY:
0.0286
AC XY:
2130
AN XY:
74468
show subpopulations
African (AFR)
AF:
0.0461
AC:
1914
AN:
41546
American (AMR)
AF:
0.0349
AC:
534
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.00749
AC:
26
AN:
3472
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5176
South Asian (SAS)
AF:
0.00249
AC:
12
AN:
4826
European-Finnish (FIN)
AF:
0.00556
AC:
59
AN:
10620
Middle Eastern (MID)
AF:
0.0306
AC:
9
AN:
294
European-Non Finnish (NFE)
AF:
0.0279
AC:
1898
AN:
68018
Other (OTH)
AF:
0.0346
AC:
73
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
223
446
670
893
1116
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
52
104
156
208
260
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0266
Hom.:
68
Bravo
AF:
0.0319
Asia WGS
AF:
0.0110
AC:
37
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.97
CADD
Benign
0.70
DANN
Benign
0.59
PhyloP100
-0.71
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs6993502; hg19: chr8-68577966; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.